Answers are grounded in this paper and cite their sources.
The convergence of whole-slide imaging (WSI), digital pathology, and artificial intelligence (AI) is transforming routine breast pathology practice. Experiences from multiple institutions have demonstrated that successful clinical deployment requires robust digital infrastructure, seamless laboratory information system integration, standardized validation, and close collaboration between pathologists and information technology teams. Following the successful implementation of a digital pathology workflow, AI has emerged as a realistic tool for routine pathology practice. Artificial intelligence applications in breast pathology have evolved from automated detection of lymph node metastases and quantitative analysis of breast biomarkers to diagnostic classification of breast lesions and prediction of treatment response and clinical outcome. Artificial intelligence-assisted workflows can reduce pathologist review time and unnecessary ancillary testing while maintaining high diagnostic performance. Rather than replacing pathologists, AI functions as an intelligent decision-support tool that enhances efficiency, reproducibility, and quality. This review summarizes current strategies for implementing digital pathology AI in routine breast pathology practice, highlights clinically validated applications, discusses practical implementation considerations, and outlines future directions toward foundation models and agentic AI systems that may further automate pathology workflows.
No takes yet. Share an insight, caveat, or question.
Zaibo Li (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: